543 related articles for article (PubMed ID: 30463604)
1. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs: A Systematic Review.
Au YK; Kananeh MF; Rahangdale R; Moore TE; Panza GA; Gaspard N; Hirsch LJ; Fernandez A; Shah SO
JAMA Neurol; 2024 May; 81(5):534-548. PubMed ID: 38466294
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
4. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus.
Kang BS; Jung KH; Shin JW; Moon JS; Byun JI; Lim JA; Moon HJ; Kim YS; Lee ST; Chu K; Lee SK
J Clin Neurosci; 2015 May; 22(5):854-8. PubMed ID: 25744078
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
7. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
Rossetti AO; Logroscino G; Bromfield EB
Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
[TBL] [Abstract][Full Text] [Related]
8. Association of seizure duration and outcome in refractory status epilepticus.
Madžar D; Geyer A; Knappe RU; Gollwitzer S; Kuramatsu JB; Gerner ST; Hamer HM; Huttner HB
J Neurol; 2016 Mar; 263(3):485-91. PubMed ID: 26725091
[TBL] [Abstract][Full Text] [Related]
9. Nonconvulsive status epilepticus after convulsive status epilepticus: Clinical features, outcomes, and prognostic factors.
Yuan F; Yang F; Li W; Yang X; Gao Q; Bi L; Jiang Y; Jiang W
Epilepsy Res; 2018 May; 142():53-57. PubMed ID: 29555354
[TBL] [Abstract][Full Text] [Related]
10. Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis.
Koh S; Kim TJ; Shin HB; Kim HK; Park B; Moon SY; Kim BG; Huh K; Choi JY
Neurotherapeutics; 2022 Sep; 19(5):1526-1534. PubMed ID: 35974294
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
[TBL] [Abstract][Full Text] [Related]
12. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.
Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N
J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with occurrence and outcome of super-refractory status epilepticus.
Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
[TBL] [Abstract][Full Text] [Related]
14. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
[TBL] [Abstract][Full Text] [Related]
15. Status epilepticus: Refractory and super-refractory.
Dubey D; Kalita J; Misra UK
Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
[TBL] [Abstract][Full Text] [Related]
16. Effects of clobazam for treatment of refractory status epilepticus.
Madžar D; Geyer A; Knappe RU; Gollwitzer S; Kuramatsu JB; Gerner ST; Hamer HM; Huttner HB
BMC Neurol; 2016 Oct; 16(1):202. PubMed ID: 27769254
[TBL] [Abstract][Full Text] [Related]
17. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
[TBL] [Abstract][Full Text] [Related]
18. A one-year prospective study of refractory status epilepticus in Modena, Italy.
Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
[TBL] [Abstract][Full Text] [Related]
19. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
Chiu WT; Campozano V; Schiefecker A; Rodriguez DR; Ferreira D; Headlee A; Zeidan S; Grinea A; Huang YH; Doyle K; Shen Q; Gómez D; Hocker SE; Rohaut B; Sonneville R; Hong CT; Demeret S; Kurtz P; Maldonado N; Helbok R; Fernandez T; Claassen J
Neurology; 2022 Sep; 99(11):e1191-e1201. PubMed ID: 35918156
[TBL] [Abstract][Full Text] [Related]
20. Refractory status epilepticus: Impact of baseline comorbidity and usefulness of STESS and EMSE scoring systems in predicting mortality and functional outcome.
Ciurans J; Grau-López L; Jiménez M; Fumanal A; Misis M; Becerra JL
Seizure; 2018 Mar; 56():98-103. PubMed ID: 29462742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
